Evidence map›Paper›PMID 25803285›Full record

ArticlePloS one2015

Effects of TiO₂ and Co₃O₄ nanoparticles on circulating angiogenic cells.

Valentina Spigoni, Monia Cito, Rossella Alinovi, Silvana Pinelli, Giovanni Passeri, Ivana Zavaroni, Matteo Goldoni, Marco Campanini, Irene Aliatis, Antonio Mutti and 2 more

Abstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Exposure-based ecotoxicity assessment of CoEnvironmental science and pollution research international · 2021
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Cobalt Oxide Nanoparticles: Behavior towards Intact and Impaired Human Skin and Keratinocytes Toxicity.International journal of environmental research and public health · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Valentina SpigoniDepartment of Clinical and Experimental Medicine. Division of Endocrinology. University of Parma and Azienda Ospedaliero-Universitaria of Parma, Parma, Italy.
Monia CitoDepartment of Clinical and Experimental Medicine. Division of Endocrinology. University of Parma and Azienda Ospedaliero-Universitaria of Parma, Parma, Italy.
Rossella AlinoviDepartment of Clinical and Experimental Medicine. Unit of Occupational and Environmental Medicine. University of Parma, Parma, Italy.
Silvana PinelliDepartment of Clinical and Experimental Medicine. Unit of Occupational and Environmental Medicine. University of Parma, Parma, Italy.
Giovanni PasseriDepartment of Clinical and Experimental Medicine. Unit of Andrology, Metabolic Bone Diseases and Endocrinology. University of Parma, Parma, Italy.
Ivana ZavaroniDepartment of Clinical and Experimental Medicine. Unit of Diabetes and prevention of associated diseases. University of Parma, Parma, Italy.
Matteo GoldoniDepartment of Clinical and Experimental Medicine. Unit of Occupational and Environmental Medicine. University of Parma, Parma, Italy.
Marco CampaniniIMEM-CNR (Istituto Materiale per l'Elettronica ed il Magnetismo - Consiglio Nazionale delle Ricerche) Institute, Parma, Italy.
Irene AliatisDepartment of Physics and Earth Sciences. University of Parma, Parma, Italy.
Antonio MuttiDepartment of Clinical and Experimental Medicine. Unit of Occupational and Environmental Medicine. University of Parma, Parma, Italy.
Riccardo C BonadonnaDepartment of Clinical and Experimental Medicine. Division of Endocrinology. University of Parma and Azienda Ospedaliero-Universitaria of Parma, Parma, Italy.
Alessandra Dei CasDepartment of Clinical and Experimental Medicine. Division of Endocrinology. University of Parma and Azienda Ospedaliero-Universitaria of Parma, Parma, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

aimSparse evidence suggests a possible link between exposure to airborne nanoparticles (NPs) and cardiovascular (CV) risk, perhaps through mechanisms involving oxidative stress and inflammation. We assessed the effects of TiO2 and Co3O4 NPs in human circulating angiogenic cells (CACs), which take part in vascular endothelium repair/replacement.

methodsCACs were isolated from healthy donors' buffy coats after culturing lymphomonocytes on fibronectin-coated dishes in endothelial medium for 7 days. CACs were pre-incubated with increasing concentration of TiO2 and Co3O4 (from 1 to 100 μg/ml) to test the effects of NP – characterized by Transmission Electron Microscopy – on CAC viability, apoptosis (caspase 3/7 activation), function (fibronectin adhesion assay), oxidative stress and inflammatory cytokine gene expression.

resultsNeither oxidative stress nor cell death were associated with exposure to TiO2 NP (except at the highest concentration tested), which, however, induced a higher pro-inflammatory effect compared to Co3O4 NPs (p<0.01). Exposure to Co3O4 NPs significantly reduced cell viability (p<0.01) and increased caspase activity (p<0.01), lipid peroxidation end-products (p<0.05) and pro-inflammatory cytokine gene expression (p<0.05 or lower). Notably, CAC functional activity was impaired after exposure to both TiO2 (p<0.05 or lower) and Co3O4 (p<0.01) NPs.

conclusionsIn vitro exposure to TiO2 and Co3O4 NPs exerts detrimental effects on CAC viability and function, possibly mediated by accelerated apoptosis, increased oxidant stress (Co3O4 NPs only) and enhancement of inflammatory pathways (both TiO2 and Co3O4 NPs). Such adverse effects may be relevant for a potential role of exposure to TiO2 and Co3O4 NPs in enhancing CV risk in humans.

Indexed as

ApoptosisCobaltEndothelium, VascularHumansLeukocytes, MononuclearMetal NanoparticlesMicroscopy, Electron, TransmissionNeovascularization, PhysiologicOxidative StressOxidesPrimary Cell CultureTitaniumCobaltcobalt oxideOxidesTitaniumtitanium dioxide

Identifiers

PMID25803285
PMCPMC4372399

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.